# OnCo record sc-101 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sc-101/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sc-101" ;
  schema:name "SC-101"@en ;
  schema:description "SC-101 is an experimental peptide-drug conjugate from ConjuStar Biologics, in phase 2 trials for nectin-4-expressing advanced solid tumours, NECTIN4-amplified triple-negative breast cancer and NECTIN4-amplified HR-positive breast cancer."@en ;
  schema:url <https://onco.cc/drugs/sc-101/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.conjustar.com/>, <https://clinicaltrials.gov/study/NCT07080619>, <https://clinicaltrials.gov/study/NCT06220838>, <https://clinicaltrials.gov/search?intr=SC-101> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Peptide-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:targets <https://onco.cc/targets/nectin4/> ;
  onco:companies <https://onco.cc/companies/conjustar-biologics/> ;
  onco:trials <https://onco.cc/trials/nct06220838/>, <https://onco.cc/trials/nct07080619/> .